Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001226232 | SCV001398537 | likely benign | Walker-Warburg congenital muscular dystrophy | 2023-12-25 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002484228 | SCV002790513 | uncertain significance | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1; Muscular dystrophy-dystroglycanopathy type B5; Autosomal recessive limb-girdle muscular dystrophy type 2I; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 | 2021-09-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004032565 | SCV005028638 | likely benign | Cardiovascular phenotype | 2023-12-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001828806 | SCV002088967 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2020-11-03 | no assertion criteria provided | clinical testing |